These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8837220)

  • 1. Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats.
    Carlsson PO; Ostenson CG; Efendic S; Langel U; Jansson L
    Regul Pept; 1996 Jul; 63(2-3):123-8. PubMed ID: 8837220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats.
    Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD
    Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The augmentation of pituitary adenylate cyclase-activating polypeptide (PACAP) in streptozotocin-induced diabetic rats.
    Tamakawa H; Miyata A; Satoh K; Miyake Y; Matsuo H; Arimura A; Kangawa K
    Peptides; 1998; 19(9):1497-502. PubMed ID: 9864055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro.
    Romanelli F; Fillo S; Isidori A; Conte D
    Neuropeptides; 1997 Aug; 31(4):311-7. PubMed ID: 9308016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
    Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
    FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.
    Mungan Z; Ertan A; Hammer RA; Arimura A
    Peptides; 1991; 12(3):559-62. PubMed ID: 1717954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitatory effects of pituitary adenylate cyclase activating polypeptide (PACAP) on neurons in the magnocellular portion of the rat hypothalamic paraventricular nucleus (PVN) in vitro.
    Uchimura D; Katafuchi T; Hori T; Yanaihara N
    J Neuroendocrinol; 1996 Feb; 8(2):137-43. PubMed ID: 8868261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.
    Chen YD; Zhou ZG; Wang Z; Gao HK; Yan WW; Wang C; Zhao GP; Peng XH
    World J Gastroenterol; 2005 Jan; 11(4):538-44. PubMed ID: 15641142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).
    Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PAC(1) receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo.
    Lamouche S; Yamaguchi N
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R510-8. PubMed ID: 11208582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.